Systemic cystic angiomatosis-Seip syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:1060
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Systemic cystic angiomatosis-Seip syndrome is an extremely rare condition that combines two distinct problems: widespread cystic angiomatosis (abnormal blood vessel growths forming cysts throughout the body, especially in bones and soft tissues) and features of Berardinelli-Seip syndrome (also known as congenital generalized lipodystrophy, where the body lacks normal fat tissue). This combination leads to a complex multi-system disease. In cystic angiomatosis, abnormal blood vessel-lined cysts develop in bones and sometimes in organs like the spleen and liver. This can cause bone pain, fractures, and skeletal deformities. The lipodystrophy component means the body cannot properly store fat, which leads to a muscular or lean appearance, insulin resistance, diabetes, enlarged liver (due to fat accumulation in the liver), and high levels of fats in the blood. Patients may also develop an enlarged spleen and other metabolic complications. Because this condition is so rare, there is no single established treatment protocol. Management is typically supportive and involves multiple specialists working together to address bone problems, metabolic abnormalities, and organ complications. Treatment may include medications to manage diabetes and high blood lipids, pain management for bone involvement, and careful monitoring for complications. Research into this condition is very limited, and much of what is known comes from individual case reports.

Also known as:

Key symptoms:

Bone painBone cysts visible on X-raysFractures from weakened bonesVery little body fat (lean or muscular appearance)Enlarged liverEnlarged spleenInsulin resistance or diabetesHigh levels of fats in the blood (high triglycerides)Skeletal deformitiesProminent muscles due to lack of fat tissueIncreased appetiteSkin darkening in body folds (acanthosis nigricans)Abdominal swelling

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Systemic cystic angiomatosis-Seip syndrome.

View clinical trials →

No actively recruiting trials found for Systemic cystic angiomatosis-Seip syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Systemic cystic angiomatosis-Seip syndrome community →

No specialists are currently listed for Systemic cystic angiomatosis-Seip syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Systemic cystic angiomatosis-Seip syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Systemic cystic angiomatosis-Seip syndromeForum →

No community posts yet. Be the first to share your experience with Systemic cystic angiomatosis-Seip syndrome.

Start the conversation →

Latest news about Systemic cystic angiomatosis-Seip syndrome

No recent news articles for Systemic cystic angiomatosis-Seip syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.What specific tests do I need to monitor my metabolic health, and how often?,Am I a candidate for metreleptin (Myalept) therapy for the lipodystrophy?,What can be done to manage or prevent bone fractures from the cystic lesions?,Should I have genetic testing, and would it help guide my treatment?,What dietary plan is best for managing my high triglycerides and diabetes?,Are there any clinical trials or research studies I could participate in?,What emergency warning signs should I watch for at home?

Common questions about Systemic cystic angiomatosis-Seip syndrome

What is Systemic cystic angiomatosis-Seip syndrome?

Systemic cystic angiomatosis-Seip syndrome is an extremely rare condition that combines two distinct problems: widespread cystic angiomatosis (abnormal blood vessel growths forming cysts throughout the body, especially in bones and soft tissues) and features of Berardinelli-Seip syndrome (also known as congenital generalized lipodystrophy, where the body lacks normal fat tissue). This combination leads to a complex multi-system disease. In cystic angiomatosis, abnormal blood vessel-lined cysts develop in bones and sometimes in organs like the spleen and liver. This can cause bone pain, fractu